beta-agonists regulate Na,K-ATPase via novel MAPK/ERK and rapamycin-sensitive pathways.

Area of Science:

• Cellular Biology
• Respiratory Physiology
• Molecular Signaling

Background:

• The sodium-potassium ATPase (Na,K-ATPase) is crucial for maintaining ion balance in alveolar epithelial cells (AECs).
• Beta-adrenergic agonists like isoproterenol (ISO) are known to influence lung cell function.
• The specific mechanisms by which ISO regulates Na,K-ATPase in AECs remain incompletely understood.

Purpose of the Study:

• To investigate if isoproterenol (ISO) regulates Na,K-ATPase in alveolar epithelial cells (AECs).
• To determine the role of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway in ISO-mediated Na,K-ATPase regulation.
• To elucidate the signaling cascades involved, including beta-adrenergic receptor, protein kinase A (PKA), and mammalian target of rapamycin (mTOR).

Main Methods:

• Primary alveolar epithelial cells (AECs) were treated with isoproterenol (ISO).
• ERK activity was measured using Western blotting and specific kinase assays.
• Na,K-ATPase alpha1 and beta1 subunit protein and mRNA levels were quantified.
• The effect of rapamycin, an mTOR inhibitor, on ISO-induced changes was assessed.

Main Results:

• ISO rapidly increased ERK activity in AECs via a beta-adrenergic receptor and PKA-dependent pathway.
• Activation of the MAPK/ERK pathway by ISO led to increased protein abundance of Na,K-ATPase alpha1 and beta1 subunits.
• This resulted in enhanced functional Na,K-ATPase activity at the basolateral membrane.
• ISO did not alter mRNA levels, but rapamycin blocked the ISO-mediated increase in Na,K-ATPase protein, indicating posttranscriptional regulation.

Conclusions:

• Isoproterenol regulates Na,K-ATPase in AECs through a signaling pathway involving PKA and ERK.
• The regulation occurs at a posttranscriptional level, influenced by mTOR.
• These findings highlight a novel mechanism for modulating ion transport in the lungs.